Lavoie S - Search Results

1

Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ): Rationale and Study Design of the Largest Global Prospective Cohort Study of Clinical High Risk for Psychosis.

Wannan CMJ, Nelson B, Addington J, Allott K, Anticevic A, Arango C, Baker JT, Bearden CE, Billah T, Bouix S, Broome MR, Buccilli K, Cadenhead KS, Calkins ME, Cannon TD, Cecci G, Chen EYH, Cho KIK, Choi J, Clark SR, Coleman MJ, Conus P, Corcoran CM, Cornblatt BA, Diaz-Caneja CM, Dwyer D, Ebdrup BH, Ellman LM, Fusar-Poli P, Galindo L, Gaspar PA, Gerber C, Glenthøj LB, Glynn R, Harms MP, Horton LE, Kahn RS, Kambeitz J, Kambeitz-Ilankovic L, Kane JM, Kapur T, Keshavan MS, Kim SW, Koutsouleris N, Kubicki M, Kwon JS, Langbein K, Lewandowski KE, Light GA, Mamah D, Marcy PJ, Mathalon DH, McGorry PD, Mittal VA, Nordentoft M, Nunez A, Pasternak O, Pearlson GD, Perez J, Perkins DO, Powers AR 3rd, Roalf DR, Sabb FW, Schiffman J, Shah JL, Smesny S, Spark J, Stone WS, Strauss GP, Tamayo Z, Torous J, Upthegrove R, Vangel M, Verma S, Wang J, Rossum IW, Wolf DH, Wolff P, Wood SJ, Yung AR, Agurto C, Alvarez-Jimenez M, Amminger P, Armando M, Asgari-Targhi A, Cahill J, Carrión RE, Castro E, Cetin-Karayumak S, Mallar Chakravarty M, Cho YT, Cotter D, D'Alfonso S, Ennis M, Fadnavis S, Fonteneau C, Gao C, Gupta T, Gur RE, Gur RC, Hamilton HK, Hoftman GD, Jacobs GR, Jarcho J, Ji JL, Kohler CG, Lalousis PA… See abstract for full author list ➔ Wannan CMJ, et al. Among authors: lavoie s. Schizophr Bull. 2024 Apr 30;50(3):496-512. doi: 10.1093/schbul/sbae011. Schizophr Bull. 2024. PMID: 38451304 Free PMC article.

2

Curcumin, quercetin, and tBHQ modulate glutathione levels in astrocytes and neurons: importance of the glutamate cysteine ligase modifier subunit.

Lavoie S, Chen Y, Dalton TP, Gysin R, Cuénod M, Steullet P, Do KQ. Lavoie S, et al. J Neurochem. 2009 Mar;108(6):1410-22. doi: 10.1111/j.1471-4159.2009.05908.x. Epub 2009 Jan 22. J Neurochem. 2009. PMID: 19183254 Free article.

3

Duration of untreated psychosis: a proposition regarding treatment definition.

Polari A, Lavoie S, Sarrasin P, Pellanda V, Cotton S, Conus P. Polari A, et al. Among authors: lavoie s. Early Interv Psychiatry. 2011 Nov;5(4):301-8. doi: 10.1111/j.1751-7893.2011.00308.x. Early Interv Psychiatry. 2011. PMID: 22032548

4

Frontal delta power associated with negative symptoms in ultra-high risk individuals who transitioned to psychosis.

Lavoie S, Schäfer MR, Whitford TJ, Benninger F, Feucht M, Klier CM, Yuen HP, Pantelis C, McGorry PD, Amminger GP. Lavoie S, et al. Schizophr Res. 2012 Jul;138(2-3):206-11. doi: 10.1016/j.schres.2012.03.033. Epub 2012 Apr 19. Schizophr Res. 2012. PMID: 22520856 Clinical Trial.

5

What are the neurocognitive correlates of basic self-disturbance in schizophrenia?: Integrating phenomenology and neurocognition. Part 1 (Source monitoring deficits).

Nelson B, Whitford TJ, Lavoie S, Sass LA. Nelson B, et al. Among authors: lavoie s. Schizophr Res. 2014 Jan;152(1):12-9. doi: 10.1016/j.schres.2013.06.022. Epub 2013 Jun 28. Schizophr Res. 2014. PMID: 23810736 Review.

6

What are the neurocognitive correlates of basic self-disturbance in schizophrenia? Integrating phenomenology and neurocognition: Part 2 (aberrant salience).

Nelson B, Whitford TJ, Lavoie S, Sass LA. Nelson B, et al. Among authors: lavoie s. Schizophr Res. 2014 Jan;152(1):20-7. doi: 10.1016/j.schres.2013.06.033. Epub 2013 Jul 15. Schizophr Res. 2014. PMID: 23863772 Review.

7

Sulcogyral pattern and sulcal count of the orbitofrontal cortex in individuals at ultra high risk for psychosis.

Lavoie S, Bartholomeuz CF, Nelson B, Lin A, McGorry PD, Velakoulis D, Whittle SL, Yung AR, Pantelis C, Wood SJ. Lavoie S, et al. Schizophr Res. 2014 Apr;154(1-3):93-9. doi: 10.1016/j.schres.2014.02.008. Epub 2014 Mar 11. Schizophr Res. 2014. PMID: 24630136

8

Biomarkers and clinical staging in psychiatry.

McGorry P, Keshavan M, Goldstone S, Amminger P, Allott K, Berk M, Lavoie S, Pantelis C, Yung A, Wood S, Hickie I. McGorry P, et al. Among authors: lavoie s. World Psychiatry. 2014 Oct;13(3):211-23. doi: 10.1002/wps.20144. World Psychiatry. 2014. PMID: 25273285 Free PMC article.

9

Correlates of electroencephalographic resting states and erythrocyte membrane docosahexaenoic and eicosapentaenoic acid levels in individuals at ultra-high risk of psychosis.

Lavoie S, Whitford TJ, Benninger F, Feucht M, Kim SW, Klier CM, McNamara RK, Rice S, Schäfer MR, Amminger GP. Lavoie S, et al. Aust N Z J Psychiatry. 2016 Jan;50(1):56-63. doi: 10.1177/0004867415571168. Epub 2015 Feb 17. Aust N Z J Psychiatry. 2016. PMID: 25690743

10

Declining transition rates to psychotic disorder in "ultra-high risk" clients: Investigation of a dilution effect.

Hartmann JA, Yuen HP, McGorry PD, Yung AR, Lin A, Wood SJ, Lavoie S, Nelson B. Hartmann JA, et al. Among authors: lavoie s. Schizophr Res. 2016 Jan;170(1):130-6. doi: 10.1016/j.schres.2015.11.026. Epub 2015 Dec 7. Schizophr Res. 2016. PMID: 26673973 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

255 results

Search Page

Filters